Catalyst Wire Dossier Catalyst Wire Dossier

A5B1 integrin monoclonal antibody

anti-α5β1 integrin monoclonal antibody · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A5B1 integrin monoclonal antibody, covering 2014-04-04 to 2014-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors [Phase 1]

See pricing